On 2/28/24, vTv Therapeutics Inc (NASDAQ: VTVT) stock enjoyed a major increase of 95.9%, closing at $16.65. Moreover, this advance was accompanied by exceptionally high trading volume at 3499% of normal. The stock has risen 74.3% during the last week but has been extremely weak relative to the market over the last nine months.
Current PriceTarget Research Rating
VTVT is expected to be a major Value Eraser reflecting capital returns that are forecasted to fall short of the cost of capital.
vTv Therapeutics is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment